I. Assessment A. Policy and Research Question Policy Question: Which use case and for what population should the Philippine DOH consider the use of RATs? Research Questions: Regulatory Approval Testing guidelines and evidence synthesis on use of RATs Diagnostic Performance a. Diagnosis of COVID-19 among asymptomatic patients b. Determination of previous exposure continue reading : Rapid antibody tests (RATs) (May 2020 reassessment)
Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR)
I. Assessment A. Policy and Research Question Policy Question: Which SARS-CoV-2 PCR test kit brand/s may be procured by the Philippine DOH for detecting COVID19 cases among suspect cases and recovering patients? Research Questions: Market availability and implementation Performance: Accuracy or Agreement Measures Resource requirements B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. continue reading : Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR)
AMTI uAI-Discover-PNA
I. Assessment A. Policy and Research Question Policy Question: Should the Department of Health accept the donation of the AMTI uAI-Discover-PNA for COVID-19 in the Philippines? Research Questions: B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. Start of Review: Not available. E. End of Review: April 14, 2020 II. Recommendation Evidence summary: AMTI uAI-Discover-PNA Rapid review: Pending continue reading : AMTI uAI-Discover-PNA
Huawei Cloud AI-Assisted Diagnosis
I. Assessment A. Policy and Research Question Policy Question: Should the Department of Health participate in the proof of concept study for Huawei Cloud Artificial Intelligence (AI)-Assisted Diagnosis for COVID-19 in the Philippines? Research Questions: Not available B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. Start of Review: Not available. E. End of Review: April continue reading : Huawei Cloud AI-Assisted Diagnosis
Rapid antibody tests (RATs)(March 2020 assessment)
I. Assessment A. Policy and Research Question Policy Question: Should the Philippine government introduce COVID-19 IgG and IgM RDT kits in detecting COVID19 cases among mild and asymptomatic at-risk cases versus no testing? Research Questions: B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. Start of Review: March 23, 2020 E. End of Review: March 25, continue reading : Rapid antibody tests (RATs)(March 2020 assessment)